Immuno-oncology Board Game - Update Pack

Update pack for the Immunooncology game delivered between 2022 - Oct 2025

As the use of immunotherapy, (IO), and particularly checkpoint inhibitors, (ICIs), is increasing at an exponential rate. The ability of healthcare teams to support patients on ICIs is important. This is increasingly relevant across haemato-oncological services, including pan-tumour teams and acute oncology. 

However, supporting staff to implement news ways of working is challenging. There is a need for engaging and effective educational resources, that address this subject. It focuses on the recognition, investigation and management of immune related adverse events, (irAEs), secondary to checkpoint inhibitor therapy. The game encourages players to discuss and answer a series of questions, allowing them to acquire knowledge and understanding, share ideas and learn from each other. Peer discussions are what helps players to enhance their learning.

The game will help clinicians to develop an understanding of areas including:

• What is oncological immunotherapy 
• Mechanisms of IO therapy
• Types of IO therapy
• What a patient journey looks like
• Potential long-term impact of IO and associated toxicity
• Episodic nature of toxicity
• Management of toxicity and how this is evolving
• Patient perception of risk and benefit
• Short/Long term response
• Personalised medication approach